Pfizer trimming research plants after buying Wyeth
By Associated PressPfizer trimming research plants after buying Wyeth NEW YORK (AP) - The world's biggest drugmaker is closing six of its 20 research facilities, reorganizing others, and cutting the jobs of roughly 15 percent of its scientists and support staff. The moves are part of Pfizer Inc.'s massive reorganization after buying drug and vaccine maker Wyeth just three and half weeks ago. The executives heading the combined research operation tell The Associated Press exclusively that integrating and reorganizing the two companies' laboratories will boost research productivity and efficiency and save money as well. That money will be poured into research on key diseases Pfizer is targeting, including Alzheimer's disease, cancer, pain and inflammation, diabetes and infectious diseases. Affected employees are being notified today. |
Upload directly from your mobile device. Learn howYouNews
This content requires the latest Adobe Flash Player and a browser with JavaScript enabled.
Click here for a free download of the latest Adobe Flash Player.
Stay Connected |
Connect with KCBYPOLL: Super Bowl |
February 3, 2012
- Coos Bay / North Bend, Oregon
